Polar Asset Management Partners’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-366,000
| Closed | -$95K | – | 831 |
|
|
2020
Q3 | $95K | Hold |
366,000
| – | – | ﹤0.01% | 529 |
|
|
2020
Q2 | $165K | Hold |
366,000
| – | – | ﹤0.01% | 383 |
|
|
2020
Q1 | $24K | Sell |
366,000
-8,600
| -2% | -$564 | ﹤0.01% | 355 |
|
|
2019
Q4 | $65K | Hold |
374,600
| – | – | ﹤0.01% | 346 |
|
|
2019
Q3 | $64K | Hold |
374,600
| – | – | ﹤0.01% | 338 |
|
|
2019
Q2 | $82K | Buy |
374,600
+174,600
| +87% | +$38.2K | ﹤0.01% | 315 |
|
|
2019
Q1 | $36K | Hold |
200,000
| – | – | ﹤0.01% | 292 |
|
|
2018
Q4 | $77K | Hold |
200,000
| – | – | ﹤0.01% | 277 |
|
|
2018
Q3 | $83K | Hold |
200,000
| – | – | ﹤0.01% | 303 |
|
|
2018
Q2 | $76K | Hold |
200,000
| – | – | ﹤0.01% | 315 |
|
|
2018
Q1 | $74K | Hold |
200,000
| – | – | ﹤0.01% | 301 |
|
|
2017
Q4 | $93K | Buy |
+200,000
| New | +$93K | ﹤0.01% | 315 |
|